Tag: ISIN:CA53946V1076

lobe-sciences-announces-closing-of-private-placement

Lobe Sciences Announces Closing of Private Placement

Vancouver, British Columbia–(Newsfile Corp. – September 8, 2022) – Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (“Lobe” or the “Company”), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease, today announced that ...

lobe-sciences-and-cantheon-capital-enter-into-exclusive-investment-agreement-to-fund-$1.5m-usd-toward-clinical-trials-in-australia

Lobe Sciences and Cantheon Capital Enter into Exclusive Investment Agreement to Fund $1.5M USD Toward Clinical Trials in Australia

Vancouver, British Columbia–(Newsfile Corp. – September 1, 2022) – Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (“Lobe” or the “Company”), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced it ...